Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2012-003391-39Phase 4Terminated
Phase 4 trial of heparin in aortic stenosis (AS) (2 arms), sponsored by Centre Hospitalier Universitaire de Montpellier. Primary endpoint: Serious procedure-related complications. Started Sep 2012; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2012-003391-39.